E-DRUG: new WHO/EDM Executive Director
----------------------------------------------------
[Dr Brundtland has announced a new executive director at WHO/HTP, the
cluster
to which the essential drug programme belongs. From a memo to all staff.
Thanks to Dr Suzuki for being a good manager over the last years, and
welcome to the first African Exec Director at WHO/EDM! WB]
Dr Yasuhiro Suzuki has been on secondment to WHO, from the Government of
Japan, for the last four years as an Executive Director. He will be
returning to Government service with his home country at the end of this
month. Dr Suzuki has made an excellent contribution to the work of WHO
over the past four years, both in providing high quality leadership in two
different clusters and as an invaluable member of the Cabinet.
Dr Anarfi Asamoa-Baah will move to the position of Executive Director,
Health Technologies and Pharmaceuticals, with effect from 1 July 2002,
bringing his broad experience at national level and as a former Senior
Policy Adviser, to this key Cluster. As Executive Director, External
Relations and Governing Bodies, Dr Asamoa-Baah has taken forward several
noteworthy innovations including the Country Focus and Civil Society
initiatives, and the creation of a new Department for Government and
Private Sector Relations.
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html